Zhi Chai1, Xiaoming Xue2, Huijie Fan1, Lin Sun3, Hongyu Cai4, Yanmiao Ma1, Cungen Ma5, Ran Zhou6. 1. Neurobiology Research Center/"2011" Collaborative Innovation Center/Basic Medical College, Shanxi University of Traditional Chinese Medicine, Jinzhong, China. 2. Department of Pneumology, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China. 3. Traditional Chinese Medicine College, Shanxi University of Traditional Chinese Medicine, Jinzhong, China. 4. Department of Nephropathy, Shanxi Provincial Hospital of Traditional Chinese Medicine, Taiyuan, China. 5. Neurobiology Research Center/"2011" Collaborative Innovation Center/Basic Medical College, Shanxi University of Traditional Chinese Medicine, Jinzhong, China; Institute of Brain Science, Shanxi Datong University, Datong, China. Electronic address: macungen2001@163.com. 6. Neurobiology Research Center/"2011" Collaborative Innovation Center/Basic Medical College, Shanxi University of Traditional Chinese Medicine, Jinzhong, China. Electronic address: zhour58@sohu.com.
Abstract
OBJECTIVE: To quantitatively assess and compare the effectiveness and safety of posterior fossa decompression with duraplasty (PFDD) and posterior fossa decompression (PFD) in treating patients with Chiari malformation type I. METHODS: PubMed, Embase, and Cochrane Library were searched through May 2017. Fourteen cohort studies comprising 3666 patients with Chiari malformation type I were included. Studies were pooled, and the relative risk (RR) and corresponding 95% confidence interval (CI) were calculated. RESULTS: The decrease in syringomyelia was better in patients in the PFDD group than in patients in the PFD group (RR = 1.57, 95% CI = 1.07-2.32, Pheterogeneity = 0.042, I2 = 56.6%). The incidence of cerebrospinal fluid leak (RR = 5.23, 95% CI = 2.61-10.51, Pheterogeneity = 0.830, I2 = 0%) and aseptic meningitis (RR = 4.02, 95% CI = 1.46-11.03, Pheterogeneity = 0.960, I2 = 0%) significantly increased among patients in the PFDD group compared with patients in the PFD group. When stratifying by age, a significantly reduced risk in the reoperation rate was observed in the adult group. However, the clinical improvement and the incidence of wound infection were not significantly different between the 2 groups. CONCLUSIONS: This study confirmed that the decrease in syringomyelia was better for patients treated with PFDD than for patients treated with PFD alone. However, no significant difference was found in the clinical improvement and the reoperation rate between the 2 groups.
OBJECTIVE: To quantitatively assess and compare the effectiveness and safety of posterior fossa decompression with duraplasty (PFDD) and posterior fossa decompression (PFD) in treating patients with Chiari malformation type I. METHODS: PubMed, Embase, and Cochrane Library were searched through May 2017. Fourteen cohort studies comprising 3666 patients with Chiari malformation type I were included. Studies were pooled, and the relative risk (RR) and corresponding 95% confidence interval (CI) were calculated. RESULTS: The decrease in syringomyelia was better in patients in the PFDD group than in patients in the PFD group (RR = 1.57, 95% CI = 1.07-2.32, Pheterogeneity = 0.042, I2 = 56.6%). The incidence of cerebrospinal fluid leak (RR = 5.23, 95% CI = 2.61-10.51, Pheterogeneity = 0.830, I2 = 0%) and aseptic meningitis (RR = 4.02, 95% CI = 1.46-11.03, Pheterogeneity = 0.960, I2 = 0%) significantly increased among patients in the PFDD group compared with patients in the PFD group. When stratifying by age, a significantly reduced risk in the reoperation rate was observed in the adult group. However, the clinical improvement and the incidence of wound infection were not significantly different between the 2 groups. CONCLUSIONS: This study confirmed that the decrease in syringomyelia was better for patients treated with PFDD than for patients treated with PFD alone. However, no significant difference was found in the clinical improvement and the reoperation rate between the 2 groups.
Authors: V Vazquez Rodriguez; C A Tello; L Piantoni; I A Francheri Wilson; E Galareto; R G Remondino; S E Bersusky; R Davies; M A Noel Journal: Spine Deform Date: 2021-04-01
Authors: H Alexander; D Tsering; J S Myseros; S N Magge; C Oluigbo; C E Sanchez; Robert F Keating Journal: Childs Nerv Syst Date: 2019-07-27 Impact factor: 1.475
Authors: Arthur Wagner; Lukas Grassner; Nikolaus Kögl; Sebastian Hartmann; Claudius Thomé; Maria Wostrack; Bernhard Meyer Journal: Acta Neurochir (Wien) Date: 2020-06-06 Impact factor: 2.216
Authors: Maria Caffo; Salvatore M Cardali; Gerardo Caruso; Elena Fazzari; Rosaria V Abbritti; Valeria Barresi; Antonino Germanò Journal: Surg Neurol Int Date: 2019-05-10